Orion Health Group Limited (OHE) Is Yet to See Trading Action on Jun 15

June 15, 2018 - By Marguerite Chambers

Shares of Orion Health Group Limited (ASX:OHE) closed at 0.75 yesterday. Orion Health Group Limited currently has a total float of 184.19 million shares and on average sees 1,484 shares exchange hands each day. The stock now has a 52-week low of 0.56 and high of 1.25.

Why More Investors Are Looking Into S&P/ASX 200 Stocks

Australia takes pride with good corporate governance, which is why it is one of Asia’s fastest growing economies today. A nation’s good corporate governance improves its growth potentials as it lures domestic and foreign investors alike to bank on its equity market. CG Watch, which publishes ranks top Asian markets in terms of corporate governance biannually, has included Australia in its recent list.

The Australian Equity Market

Orion Health Group Limited is traded on the The Australian Securities Exchange (ASX) one of the biggest stock exchanges in Asia. And Orion Health Group Limited also included in its list. As of May 2014, over 2,000 companies are listed on the ASX, boasting with a total market capitalization of almost A$2 trillion.

One of the benchmark indices in Australia is the S&P/ASX 200, which tracks as much as 200 most actively traded stocks on the ASX.

The S&P/ASX 200

The S&P/ASX 200 carries on from All Ordinaries, which was formed in January 1980 to serve as the main Australian benchmark index, when it was established in April 2000. It had started at 3,133.30 points.

Continuing from the history of All Ordinaries, the S&P/ASX 200 had hit its all-time low of 1,358.50 points in November 1992. Eventually, it was able to recover, hitting its all-time high of 6,828.70 points during the same month in 2007. In February of that year, the S&P/ASX 200 had first reached the 6,000 mark. Investors had flocked the ASX that time, seeking for safe-haven assets in preparation for the Global Financial Crisis of 2008 amid early signs pointing out to its onslaught. Australia have always boasted with a compelling borrowing environment, which is why investors have always relied to its economy for valuable investment growth.

The S&P/ASX 200 is rebalanced quarterly by a panel of five members, the Index Committee. The review happens on the 16th of every quarter-end month— March, June, September, and December. Up to 200 companies make up the S&P/ASX, depending on their liquidity, market capitalization, and other factors. Orion Health Group Limited liquidity gives it an ability to perform the obligations with ease.

The S&P/ASX 200 is a free-float market-capitalization-weighted index, which means that stocks are evaluated based on their respective market capitalizations with respect to their share prices. Given this, stocks held by venture capitalists and the government are excluded since they are not often traded on the ASX.

When the components of the S&P/ASX 200 were last reviewed on September 16, six stocks had been removed while six new stocks had been included. Roughly 40% of the index is composed of the financial sector.

The S&P/ASX 200 represents about 80% of the total market valuation on the ASX, which is why it is an important indicator of the Australian economy. Similarly, it has a huge impact on the entire Asian economy.

Investors can surely benefit from the low interest rates and a healthy equity market in Australia. Orion Health Group Limited has relatively good liquidity. That being said, investing in ASX stocks is highly recommended for those who are seeking higher near-term and long-term returns alike. Investors prefer the companies like Orion Health Group Limited where they can easily see its liquidity ratio.

Another recent and important Orion Health Group Limited (ASX:OHE) news was published by Fool.com.Au which published an article titled: “Why I expect successful companies like Xero Limited will keep winning” on June 07, 2018.

Orion Health Group Limited engages in the development, implementation, hosting, sale, and support of software for the healthcare IT market. The company has market cap of $138.15 million. The firm offers Amadeus, a platform for population health management and precision medicine that provides healthcare professionals with an approach to acquire, measure, analyze, and present actionable clinical and claims data, as well as non-traditional data; Rhapsody, an intelligent integration for healthcare systems; and Amadeus Analytics that enables healthcare organizations to identify gaps in care, improve clinical outcomes, address quality-reporting requirements, and improve the cost of care. It currently has negative earnings. It also provides Coordinate, which enables patient-centric care through decision-making and actions; Engage, a solution that leverages data sources to provide individuals with access to their own health record; Communicate, a healthcare communications solution that provides protected communication between patients, healthcare providers, and organizations across desktop and electronic medical systems; Medicines, an integrated solution for a patient-centric view of medications; and Medicare Shared Savings Program Management, a real-time accountable care organizations performance monitoring and operational management solution to derive the maximum shared savings available from the MSSP.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.